PERSPECTA

News from every angle

← Back to headlines

AstraZeneca's Imfinzi Receives EU Approval for Early Gastric/Gastroesophageal Cancers

AstraZeneca has announced that its drug Imfinzi has received approval in the European Union for the treatment of early gastric and gastroesophageal cancers.

25 Mar, 17:02 — 25 Mar, 17:02
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual14d ago

AstraZeneca (AZN) Announces EU Approval of Imfinzi for Early Gastric/Gastroesophageal Cancers

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Philippine Sugar Producers Request Emergency Cloud Seeding Amid El Niño Threat

just now

Philippines Approves P10 Per Liter Fuel Subsidy for PUVs

just now

Philippine Official Calls for Probe into Oil Industry Cartel

just now